EFFECT OF FIBRIN-TARGETING ON CLOT LYSIS WITH UROKINASE-TYPE PLASMINOGEN-ACTIVATOR

被引:6
|
作者
LIJNEN, HR
DEWERCHIN, M
DECOCK, F
COLLEN, D
机构
[1] Center for Thrombosis and Vascular Research, University of Leuven, Leuven
关键词
chimeric plasminogen activators; fibrin-specific clot lysis; fibrin-specific monoclonal antibody; single chain urokinase-type plasminogen activator; thrombolysis; tissue-type plasminogen activator;
D O I
10.1016/0049-3848(90)90249-C
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of fibrin-targeting of urokinase-type plasminogen activator (u-PA) on its fibrinolytic potency was studied using recombinant fusion proteins of u-PA with the NH2-terminal region of tissue-type plasminogen activator (t-PA/u-PA) and chemical complexes of u-PA with F(ab′)2 fragments of a fibrin specific monoclonal antibody (u-PA/MA-15C5-F(ab′)2). Two chain derivatives of a low Mr variant of u-PA comprising amino acids Leu144-Leu411 (tcu-PA-32k), obtained by cleavage of recombinant single-chain u-PA (rscu-PA-32k) with thrombin (rtcu-PA-32k/T) or plasmin (rtcu-PA-32k/P) were investigated. The plasmin-derived two chain u-PA moieties, rtcu-PA-32k/P, rt-PA/tcu-PA-32k/P and rtcu-PA-32k/MA-15C5-F(ab′)2/P had high specific activities in amidolytic and fibrin plate assays (130,000 and 150,000 IU/mg u-PA, 43,000 and 71,000 IU/mg u-PA and 32,000 and 56,000 IU/mg u-PA respectively). The thrombin-derived two chain u-PA moieties had a very low amidolytic activity, corresponding to ≤ 1 percent of that of their plasmin-derived counterparts. On fibrin plates, however, rtcu-PA-32k/T had a negligible activity, whereas rt-PA/tcu-PA-32k/T and rtcu-PA-32k/MA-15C5-F(ab′)2/T had specific activities of 12,000 and 25,000 IU/mg u-PA respectively. The catalytic efficiency for plasminogen activation of rtcu-PA-32k/MA-15C5-F(ab′)2/T is 4,000-fold lower than that of rtcu-PA-32k/MA-15C5-F(ab')2/P, but its concentration required for 50 percent lysis in 2 hours of a 125I-fibrin labeled plasma clot in human plasma (C50) is only 25-fold higher. The catalytic efficiency of rt-PA/tcu-PA-32k/T is 1,600-fold lower and the C50 100-fold higher than that of rt-PA/tcu-PA-32k/P. The catalytic efficiency and the fibrinolytic potential of rtcu-PA-32k/T are negligible as compared to that of rtcu-PA-32k/P. These observations may be explained by conversion of the thrombin derived two chain u-PA moeities to their plasmin-derived analogues at the fibrin surface. This conversion appears to be most efficient for the antibody conjugate which has a high fibrin-affinity, less efficient for the t-PA/u-PA chimera which has only moderate fibrin-affinity, and negligible for the unconjugated u-PA moiety which has no fibrin-affinity. These findings illustrate the importance of plasmin-mediated positive feedback mechanisms in u-PA mediated clot lysis. © 1990.
引用
收藏
页码:333 / 342
页数:10
相关论文
共 50 条
  • [1] POTENTIATION BY LYS-PLASMINOGEN OF CLOT LYSIS BY SINGLE OR 2 CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR OR TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    WATAHIKI, Y
    SCULLY, MF
    ELLIS, V
    KAKKAR, VV
    [J]. THROMBOSIS AND HAEMOSTASIS, 1989, 61 (03) : 502 - 506
  • [2] POTENTIATION BY LYS-PLASMINOGEN OF CLOT LYSIS BY SINGLE OR 2 CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR OR TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    WATAHIKI, Y
    SCULLY, MF
    ELLIS, V
    KAKKAR, VV
    [J]. THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 83 - 83
  • [3] A MONOCLONAL-ANTIBODY SPECIFIC FOR 2-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - APPLICATION TO THE STUDY OF THE MECHANISM OF CLOT LYSIS WITH SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN PLASMA
    DECLERCK, PJ
    LIJNEN, HR
    VERSTREKEN, M
    MOREAU, H
    COLLEN, D
    [J]. BLOOD, 1990, 75 (09) : 1794 - 1800
  • [4] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND MALIGNANCY
    DUFFY, MJ
    [J]. FIBRINOLYSIS, 1993, 7 (05) : 295 - 302
  • [5] ENHANCEMENT OF CLOT LYSIS INVITRO AND INVIVO WITH A BISPECIFIC MONOCLONAL-ANTIBODY DIRECTED AGAINST HUMAN FIBRIN AND AGAINST UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    KUROKAWA, T
    IWASA, S
    KAKINUMA, A
    STASSEN, JM
    LIJNEN, HR
    COLLEN, D
    [J]. THROMBOSIS AND HAEMOSTASIS, 1991, 66 (06) : 684 - 693
  • [6] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 I IN BREAST-CANCER CELLS
    WAJIMA, T
    DEGEN, D
    ORIZ, V
    VONHOFFOLIN, DD
    [J]. THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1284 - 1284
  • [7] BIOCHEMISTRY AND FIBRIN SPECIFICITY OF SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    LIJNEN, HR
    COLLEN, D
    [J]. HAEMOSTASIS, 1986, 16 : 32 - 32
  • [8] THE CHICKEN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENE
    LESLIE, ND
    KESSLER, CA
    BELL, SM
    DEGEN, JL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (03) : 1339 - 1344
  • [9] A CELLULAR RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    BELIN, D
    BACCINO, D
    WOHLWEND, A
    ESTREICHER, A
    HUARTE, J
    VASSALLI, JD
    [J]. THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 46 - 46
  • [10] THE MURINE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENE
    DEGEN, SJF
    HECKEL, JL
    REICH, E
    DEGEN, JL
    [J]. BIOCHEMISTRY, 1987, 26 (25) : 8270 - 8279